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1,1-Dichloroethylene Hepatotoxicity:
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Distribution and Binding of 14C
Radioactivity Following Inhalation
Exposure in Rats
by Rudolph J. Jaeger,* Lawrence G. Shoner,* and
Linda Coffman*
1,1-Dichloroethylene is reported to produce renal tumors in male mice. It is an hepatotoxin in fasted
rats after inhalation. We found that trichloropropane epoxide, an inhibitor ofepoxide hydrase, enhances
hepatic injury as measured by serum sorbitol dehydrogenase elevation. A significant elevation of hepatic
citric acid concentration was seen in fasted but not fed rats. We hypothesized that mitochondrial injury
was associated with inhibition of the tricarboxylic acid cycle and postulated that monochloroacetic acid
was a toxic metabolite of 1,1-DCE. Fluoroacetic acid and chloroacetic acid were similar in their ability to
inhibit oxygen uptake when pyruvic and malic acids were substrates in isolated mitochondria sup-
plemented with adenosine diphosphate.
In experiments where 1,1-DCE metabolism was estimated, no difference between the rate ofuptake in a
2-hr period was detected between fed and fasted animals. Urinary output of radioactivity at 26 hr for
fed and fasted rats was similar. Water-soluble (i.e. TCA-soluble) 1,1-DCE metabolites were found in
tissues of fasted rats in excess of that seen in fed rats. The kidney had the largest concentration of total
metabolites. Tissue-bound, or TCA-insoluble, radioactivity was associated with the mitrochondrial and
microsomal fraction offasted rats in excess ofthat seen in fed rats. The disappearance of TCA-insoluble
radioactivity from the mitochondrial and microsomal fractions was comparable in rate between fed and
fasted rats respectively. These results suggest that 1,1-DCE is metabolized quite rapidly in the organism to
TCA-soluble components which are excreted by the kidneys. Metabolites of 1,1-DCE may enter the
metabolic pool, since a reasonably short turnover of 14C-labeled, bound material was observed. The
metabolite of 1,1-DCE appears to inhibit the mitochondria so thatcitric acid accumulates. This may occur
by a process of lethal synthesis.
Introduction
1,l-Dichloroethylene (l,1-DCE, vinylidene chlo-
ride) has recently been reported by Maltoni to pro-
duce renal tumors in mice following inhalation
exposure (1). These observations follow the earlier
revelation that vinyl chloride, a closely related
compound, is a hepatocarcinogen in man and
experimental animals (2). By analogy, therefore,
vinylidene chloride should be regarded as a sus-
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pected human carcinogen. The toxicology of
1,1-DCE has been reported by Irish (3) and Pren-
dergast et al. (4). Their observations demonstrate
clearly that the compound produces hepatic and
renal damage following inhalation exposure. No
further work was reported in the literature until the
reports of Jenkins et al. (5, 6), which attempted to
elucidate some of the factors which altered the tox-
icity of 1,11-DCE. More recently, work from our
laboratory at the Harvard School of Public Health
has attempted to elucidate the mechanism of action
of this acutely injurious plastics monomer (7-13).
l,l-DCE has been described by Reynolds as an
"'exquisite toxin" producing injury unlike that seen
December 1977 113with a number of other chlorinated compounds (14)
and with a rapidity that suggests a specific and de-
finable lesion.
This report presents information from our
laboratory on the mechanism of l,l-DCE-induced
hepatotoxicity and the reason for the potentiation of
this injury by fasting and also attempts to provide a
framework in which results on tissue distribution
and binding of radioactivity may be related to the
proposed mechanism of action. This and previous
work will be used in an attempt to explain the
mechanism by which injury is produced.
Materials and Methods
Male Holtzman rats (200-350 g) were used for
these studies. The rats were housed in air-
conditioned quarters and supplied with Purina rat
chow and water ad libitiim. Lights were on from 6
AM to 6 PM. Where indicated, rats were fasted for
18 hr prior to exposure or briefly prior to treatment.
Inhalation exposures were done as previously de-
scribed (10). Trichloropropane epoxide, an epoxide
hydrase inhibitor (15), was administered as a 1 or
10% solution in 0.5% methyl cellulose, 0.5% Tween
80. Serum sorbitol dehydrogenase activity was
measured as described by Korsrud et al. (16). Citric
acid concentrations in the liver were measured ac-
cording to the method of Henry (17). Oxygen up-
take was measured by using a Yellow Springs Oxy-
graph. Oxygen consumption was determined using
a standard curve supplied with the instrument. Pro-
tein concentration was determined according to the
method of Lowry (18). Chemicals and reagents
were of the highest purity available.
"4C-labeled 1,l-DCE was purchased from the
New England Nuclear Company. Funds for this
purchase were the generous gift ofthe Dow Chemi-
cal Company. Tissue fractions were prepared ac-
cording to the method of Hook et al. (19). Radioac-
tivity was measured in the TCA-soluble and TCA-
insoluble precipitates. Where indicated, precipi-
tates were extracted exhaustively with chloroform.
Samples were digested using a tissue solubilizer
purchased from New England Nuclear Co.; they
were decolorized by use of hydrogen peroxide.
Radioactivity was determined using a Searle Isocap
300 refrigerated scintillation spectrometer. DPM
were determined using an external standard via the
channels ratio method.
Statistical analysis was done by using the
Student's t-test for significance ofdifferences and a
p value < 0.05 was considered significant.
Results
Since our earlier observations have shown that
I,l-DCE hepatotoxicity was diminished in animals
pretreated with inducers of the mixed function ox-
idase system, we attempted to ascertain if
metabolism might be important in the toxicity of
l,l-DCE. Such efforts require the direct measure-
ment of I,l-DCE biotransformation. Lacking this
capability initially, we attempted to investigate if a
potential intermediate ofmixed function oxidase ac-
tivation of l,l-DCE, namely an epoxide, might
exist. Data in Table 1 show that trichloropropane
epoxide (TCPE), an epoxide hydrase inhibitor (15),
is able to increase significantly the toxicity of
I,I-DCE in fasted rats. At constant dose,
enhancement of toxicity is proportional to the con-
centration ofthe TCPE administered, and suggests
that the action of TCPE may be competitive.
Larger doses of TCPE are lethal but not
hepatotoxic. It should be noted that we also ob-
served a slight, but not significant, reduction of
hepatic glutathione concentration in animals pre-
treated with TCPE (see discussion). The possibility
exists that this decrease in hepatic glutathione may
have produced the enhancement of 1, 1-DCE toxic-
ity that was observed.
Table 1. Effects of trichloropropane epoxide on the toxicity
of 1,1-DCE.-
Serum sorbitol dehydrogenase activity, at
TCPE (0.1 ml/kg Po concentration, IU/ml
Exposure Vehicle TCPE
Air control 8.3 + 1.7 5.7 + 0.3 5.4 ± 0.7
n= 14 n = 11 n=7
l,l-DCE 62.0 + 120b 142.0 + 5.OC 536.0 + 125.Oc
n= 19 n= 16 n=6
aExposure: Holtzman rats, fasted, 100-150 ppm DCE x 4 hr;
killed at 6 hr.
bp < 0.05 compared to air control.
Cp < 0.05 compared to air control or vehicle-treated, 1,1-DCE
exposed group.
Henschler has suggested (20) that l,1-DCE may
be converted to chloroacyl chloride, which would
rearrange to monochloroacetic acid. We tested the
possibility that monochloroacetic acid might result
in mitochondrial injury and lead to the accumula-
tion of citric acid within the livers of animals ex-
posed to l,l-DCE. This hypothesis follows the
lethal synthesis hypothesis of Peters (21) that
fluoroacetic acid is converted to fluorocitric acid
and this compound inhibits the enzyme aconitase.
Citric acid accumulates as a result. Data in Table 2
show that animals exposed to 1,1-DCE following 18
hrfast did indeed have a highly significant elevation
(416%) of liver citric acid and a 636.4-fold increase
in SDH activity. Liver citric acid levels in fed ani-
mals were higher but, following exposure, citric
acid concentrations were not significantly elevated
(122% of control). A 100-fold elevation of SDH ac-
tivity was observed in these animals.
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serum sorbitol dehydrogenase activity.a.
Fasted, air-exposed
Fasted, I,1-DCE-exposed
Change, j,l
Fed, air-exposed
Fed, I,l-DCE-exposed
Change, ,ul
Citric acid,
mg/100 g
8.33 + 1.07 (n = 9)
34.71 + 4.32 (n = 1O)b
416
22.74 + 1.26 (n = 10)
27.89 + 2.96 (n = 10)
122
Sorbitol dehydrogenase,
IU/ml
5.0 + 0.5 (n = 10)
3181.9 ± 674.8 (n = 9)"
636.4-fold
5.4 + 0.8 (n = 10)
539.1 + 163.3 (n = 1O)b
99.8-fold
"Exposure: Holtzman rats, 250 ppm l,l-DCE x 4 hr; killed at 6 hr.
bp < 0.05 compared to corresponding control.
In order to estimate the toxicity of chloroacetic
acid as a metabolite of I,l-DCE, we conducted a
series of LD5,, determinations using 2-fluoro-
ethanol, 2-chloroethanol and 2,2-dichloroethanol
in fed or fasted Holtzman rats. We attempted to
determine if there would be a fed/fasted difference
in toxicity for these halo acid precursors. No such
difference was found. We observed that the mono-
chloroethanol LD,50 was between 0.6 and 1.05
mmole/kg, while the LD5,, for fluoroethanol was be-
tween 0.02 and 0.08 mmole/kg, an approximately
10-fold difference. The LD50 ofdichloroethanol was
in excess of 8 mmole/kg. The monochloroethanol
and monofluoroethanol LD5,, values compare
favorably with those reported by Hayes et al. (22)
for monochloro- and monofluoroacetic acids, re-
spectively.
Table 3 shows the effect of fluoroacetic acid in-
cubation on the oxygen uptake of mitochondria in-
cubated alone or with pyruvic and malic acids as
substrate and adenosine diphosphate as phosphate
acceptor (state III conditions). Similar data for
chloroacetic acid are shown in Table 4. It can be
seen that fluoroacetic acid (Table 3) results in a
significant increase of oxygen uptake by mitochon-
dria in the absence of substrate at 2 and 5mM
fluoroacetic acid. A similar, significant, elevation
was observed with chloroacetic acid (Table 4) at 5
mM. In the presence of substrate, both fluoroace-
tate and chloroacetate resulted in an inhibition of
the enhanced oxygen uptake that was observed in
mitochondria alone (929 and 110% compared to
149%, fluoroacetate; 164% and 158% compared to
178%, chloroacetate). Fluoroacetate was much
more effective at inhibiting oxygen uptake in the
presence of substrate than was chloroacetate. In
the presence of both substrate and ADP, both
fluoroacetate and chloroacetate significantly in-
hibited the increased oxygen uptake that was
associated with state III conditions. Again,
Table 3. Effect of fluoroacetic acid (FA) preincubation on the oxygen uptake of mitochondria incubated with
pyruvic-malic acid (substrate) and adenosine diphosphate (ADP).
Oxygen uptake, nmole 02/min-mg protein" Mitochondria control activity, %
Mitochondria Mitochondria
FA, Mitochondria Mitochondria + substrate Mitochondria Mitochondria + substrate
mM alone + substrate + ADP alone + substrate + ADP
0 1.47 ± 0.25 2.20 ± 0.37 2.84 ± 0.67 100 149 193
(control)
2.0 2.57 0.21b 1.35 0.13b 0.91 ± 0. 1" 174 92 61
5.0 2.49 0.18b 1.62 0.33 1.19 0.29b 169 110 80
"Values shown are the means ± SEM of6 determinations per group.
bSignificantly different from corresponding control activity.
Table 4. Effect of chloroacetic acid (CA) preincubation on the oxygen uptake of mitochondria incubated with
pyruvic-malic acid (substrate) and adenosine diphosphate (ADP).
Oxygen uptake, nmole 02/min-mg protein" Mitochondria control activity, %
Mitochondria Mitochondria
CA, Mitochondria Mitochondria + substrate Mitochondria Mitochondria + substrate
mM alone + substrate + ADP alone + substrate + ADP
0 1.12 ± 0.23 2.00 ± 0.27b 2.54 0.21b 100 178 227
(control)
2.0 1.65 ± 0.17 1.83 ± 0.18 1.43 ± 0.36b 147 164 128
5.0 2.60 + 0.76b 1.77 + 0.27 1.56 0.29b 232 158 139
"Values showni are the means ± SEM of 6 determinations per group.
bSignificantly different from corresponding control activity.
December 1977 115fluoroacetic acid was quantitatively more effective
at inhibiting oxygen uptake. These results are sug-
gestive that fluoroacetate and chloroacetate are
similar in their ability to inhibit oxygen uptake of
mitochondria under state III conditions. This ob-
servation supports but does not prove our
hypothesis that chloroacetic acid, by a process of
lethal synthesis, is converted into monochlorocitric
acid, which inhibits the enzyme aconitase.
In Figure 1, the recirculating chamber that was
used in our studies is illustrated. This chamber de-
sign permitted four rats to be exposed simultane-
ously. Disappearance curves for 1,I -DCE from this
chamber are shown in Figure 2. It can be seen that a
very slight, nonsignificant decrease does occur over
FIGURE 1. Recirculating exposure chamber.
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FIGURE 2. Disappearance curves for l,l-DCE. Initial concen-
tration was ca. 2000 ppm. Each experiment was conducted
with four rats in the chamber. Line is calculated as the line of
best fit by the least squares method.
the 120-min time period given an empty chamber or
a chamber containing four dead rats. In live fed or
fasted rats, the data show clearly that there is no
significant difference between the rate of uptake of
1, I-DCE.
In Figure 3, the distribution of '4C radioactivity
in various organs, 30 min following a 2 hr exposure
of fed or fasted rats, is shown. There was no sig-
nificant difference between the amounts of radioac-
tivity found in brain from fed or fasted rats. A
slightly higher content of total radioactivity was
seen in heart from fasted rats. Spleen and sera dem-
onstrated that a significant increase in total
radioactivity could be observed in fasted rats. The
largest amount oftotal radioactivity was detected in
the kidneys of fasted rats. The majority of this was
water- or TCA-soluble. In the liver, a significant
and larger portion than that radioactivity found in
kidney was in the TCA-insoluble form, represent-
ing either 14C tightly bound to tissue constituents,
or 14C that had entered the metabolic pool. In con-
trast, the large amount of radioactivity found in the
kidneys of fasted rats at this time suggests that a
substantial amount of metabolism of I,l-DCE has
occurred, and this metabolism produces a TCA-
soluble product which is excreted via the kidney.
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FIGURE 3. Distribution of 14C radioactivity in various organs.
Exposure at t = 0 was 2000 ppm and the rats were killed at 30
min. The exposure was terminated by venting the chamber in
a hood.
In Figure 4, the subcellular distribution of 14C in
the liver 30 min following a 2-hrexposure, is shown.
In all liver fractions from fasted animals, signifi-
cantly more radioactivity was found than in similar
fractions from fed animals. The radioactivity in
mitochondria and microsomes from fed or fasted
rats is largely in the TCA-insoluble fraction. The
cytoplasm fraction contained substantial amounts
of TCA-soluble radioactivity, suggesting that a
metabolite was present. In the mitochondrial and
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FIGURE 4. Subcellular distribution of 14C activity in liver. Ex-
perimental details given in legends to Figs. 1-3 and text.
T...
.. .... ... ...
2 3 4 5 6
i= R± S.E.(n=4)
- fasted
.fed
2 3 4 5 6
2 3 4 5 6
HOURS
microsomal fraction this radioactivity accounted for
a minority of the 14C activity that was detected.
Significant amounts ofthe radioactivity in these two
fractions was chloroform-soluble, suggesting that
lipid binding of "C might constitute a substantial
site of loss for the radiolabel.
The disappearance curves of TCA-insoluble 14C
radioactivity from subcellular fractions of the liver
are shown in Figure 5. It can be seen that the
mitochondrial and microsomal fractions from fasted
rats, which contained significantly more activity
than fed rats, had approximately the same time
course as that seen in fed animals: a T1,2 in the vicin-
ity of 2-3 hr. The amount of radioactivity in the
cytoplasmic fraction was reasonably constant and
higher in fasted animals. These results suggest that
while more TCA-insoluble radioactivity is found in
the mitochondrial and microsomal fractions of liv-
ers from fasted animals, the turnover time is rapid
and may represent radioactivity which has entered
the metabolic pool rather than TCA-insoluble
radioactivity covalently bound to protein or other
tissue constituents.
Table 5 shows the excretion of '4C radioactivity
into the urine. Groups of four fed or fasted rats
were exposed to I,l-DCE ('4C) for 2 hr at an initial
concentration of 2000 ppm and the animals were
FIGURE 5. Disappearance curves ofTCA-insoluble '4C activity
from subcellular fractions of liver. These data correspond to
the experiment shown in Fig. 2 using animals killed at the
time indicated. See text for details.
killed 24 hr after exposure. The data show that of
the calculated total dose absorbed, 36.7% and
36.5%, was recovered in the urine of fed rats and
fasted rats, respectively. When the chemical dis-
tribution of radiolabel in the urine was determined,
no fed or fasted differences were seen in ether-
extractable fractions from acidified urine. Very lit-
tle radioactivity was chloroform-extractable from
the alkaline urine. These results suggest that differ-
ences in metabolite distribution do not exist be-
tween fed and fasted rats, and excess ofone metab-
olite over another does not explain the toxicity dif-
ferences that are observed.
Table 5. Excretion of '4C radioactivity in urine.a
Fed Fasted
Total DPM in 26-hr urine 594,048 ± 48,205 638,675 ± 59,025
% of total dose 36.7 ± 3.3 36.5 ± 4.1
aGroups of four fed or fasted rats were exposed to 4C-i_,1-
DCE for 2 hr at an initial concentration of 2000 ppm and sac-
rificed 24 hr after exposure.
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117Discussion
In the present report we have shown that the tox-
icity of 1,l-DCE is modified when animals are
pretreated with trichloropropane epoxide. This
suggests but does not prove the involvement of an
epoxide intermediate in the toxicity of I,I-DCE.
There currently exists no information on the
metabolism of vinyl chloride or vinylidene chloride
epoxides by the enzyme epoxide hydrase. If it is
shown that epoxide hydrase is unable to hydrate
such small epoxides such as result from vinyl
chloride or vinylidene chloride metabolism, then an
alternate explanation for our observation must be
found. As noted under results, we observed that
glutathione concentration was decreased 18%
below control value following the administration to
fasted rats ofTCPE at a concentration of 10% in an
oral dose of0.1 ml/kg (4.76 + 0.50 mg GSH/I00 g in
H,O control vs. 3.90 + 0.42 mg GSH/100 g in the
TCPE group). This decrease, although not statisti-
cally significant between groups, may have ac-
counted for the enhanced toxicity that followed
combined TCPE and I,l-DCE exposure.
Some controversy exists on the role of the
MFOS in the activation of l,l-DCE. Should epox-
ide hydrase not be involved, our indirect evidence
of MFOS activation would be weakened. We re-
ported (11) that the MFOS inhibitor SKF 525 A did
not decrease the toxicity of l,l-DCE (1000 ppm x 4
hr, fasted rats). In subsequent experiments re-
ported in 1975 but as yet unpublished (12) we
showed that a larger dose of SKF 252 A (75 mg/kg,
IP) did protect against the toxicity of l,l-DCE (200
ppm x 4 hr). The expected elevation of serum
transaminase in vehicle-treated, fasted rats exposed
to l,l-DCE was decreased to one halfby treatment
with this inhibitor of MFOS. Further, VCM, which
is known to be activated by the MFOS, competi-
tively blocked the toxicity of l,l-DCE at concen-
trations of 200-2000 ppm (11), conditions where
VCM metabolism is saturated (23).
Our determination that hepatic citric acid levels
became elevated following exposure to l,l-DCE
suggests that I,I-DCE affect the mitochondria with
an attendant inhibition of the tricarboxylic acid
cycle. This postulation of mitochondrial damage is
consistent with our previously-reported mor-
phologic observations (14). Our hypothesis, based
on the reports of Henschler (20) and Hathway (24)
that chloroacyl chloride is converted into mono-
chloroacetic acid, which may, by a process of lethal
synthesis, be converted into chlorocitric acid which
inhibits the enzyme aconitase, is shown by the
similar effects between monochloroacetic acid and
monofluoroacetic acid. Both compounds inhibit
oxygen uptake in isolated mitochondria when
pyruvic and malic acids are used as the substrate.
In preliminary experiments, using isolated
mitochondria with succinate as the substrate, we
are unable to show an inhibitory effect of mono-
chloroacetic acid on oxygen uptake. When acetic
acid was used as substrate, oxygen uptake was
inhibited (25). These results suggest that whatever
inhibition has occurred is at an enzymatic site prior
to the metabolism of succinate. It should be noted
that we have found that oxygen uptake of whole-
liver homogenates from animals treated with
1,l-DCE and supplemented with succinate is inhib-
ited (13). This result suggests that the inhibitory
effect of I, I-DCE on mitochondria is more complex
than merely a blockage or inhibition at some step in
the TCA cycle. Our observation of oxygen uptake
inhibition is consistent with the report of Hayes et
al. (22) suggesting that monochloroacetic acid tox-
icity was similar in some respects to monofluoro-
acetic acid, i.e., inhibition of 14C acetate
metabolism. The observation was made by them
that sufficient differences existed to suggest that
monochloroacetic acid has a different mechanism of
toxicity from monofluoroacetic acid. It should be
noted that monochloroacetic acid is a direct alkylat-
ing agent (26).
With regard to our observations on the uptake of
l,l-DCE in fasted rats versus fed rats, it appears
that, if uptake from the recirculating exposure
chamber is an accurate measure of metabolism in
vivo, there is no difference due to fasting in the rate
of metabolism under these circumstances. Further,
the similarity of 24-hr output of radioactivity fol-
lowing exposure suggests that overall there is no
difference in the amount of metabolism.
We did measure significantly more water-soluble
14C radioactivity in the kidneys of fasted rats at 30
min following a 2-hr exposure. A significantly
greater amount of water-soluble radioactivity was
found in the liver cytoplasm from fasted rats. This
suggests that while no significant differences in
metabolism exist between the fasted and fed rat as
reflected by uptake from the recirculating chamber
or 26-hr output, there does appear to be a significant
difference of pathway chosen in vi4io for the prod-
ucts of metabolism. Further, the observation of
substantially larger amounts of 14C radioactivity in
the kidneys at early times ofexposure suggests that
concentration differences may exist between the
liver and kidneys in these two treatment groups.
In conclusion, we suggest that an epoxide inter-
mediate may be formed upon l,j-DCE metabolism
in the liver. Based on the reports of Reichert and
Bashti and others (20, 24, 27) we believe that
monochloroacetic acid may be the toxic metabolite
Environmental Health Perspectives 118responsible for the observed toxicity. Our results
are not inconsistent with the results of Hayes et al.
(22) and the statement by Van Duuren et al. (26)
that monochloroacetic acid is a direct alkylating
agent.
Lastly, the acute toxicity of 1,I-DCE may be
such that liver cells are destroyed rather than trans-
formed by this compound; thus hepatocellular car-
cinogenesis may be an unlikely event due to acute
cellular toxicity. However, the production of an al-
kylating agent and its concentration by the kidney,
as well as species differences between rats and
mice, could be a likely explanation for the observa-
tion that mice do develop renal tumors following
long-term exposure to 1,1-DCE while rats only
show significant hepatocellular injury.
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